A phase I study of E7050 in subjects with solid tumors.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Golvatinib (Primary)
- Indications Gastric cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 21 Jan 2014 According to ClinicalTrials.gov, status changed from recruiting to completed.
- 16 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Sep 2011 New trial record